StatPearls, LLC

  • Diabetic Ketoacidosis
  • Insulin
  • Insulin Aspart
  • Off-Label Use

Aspart Insulin

This activity discusses the indications, mechanism of action, administration, adverse effects, contraindications, monitoring, and toxicity of insulin aspart, a rapid-acting, human insulin analog FDA-approved for diabetes management. Insulin aspart can also be used to treat diabetic ketoacidosis, though this is an off-label use. This initiative facilitates informed decision-making and optimization of dosage regimens by equipping healthcare professionals with comprehensive knowledge while minimizing adverse reactions. The interprofessional healthcare team’s pivotal role in managing insulin aspart therapy is highlighted, and collaborative approaches for improving patient outcomes are emphasized.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1.5 creditsAAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABA — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABP — Lifelong Learning and Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 10 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left